Sarah E Messiah
Sarah E Messiah is an expert in Pediatrics at The University of Texas Southwestern Medical Center (United States). As of October 2026, ScienceLeadR ranks Sarah E Messiah in the top 1% of experts worldwide for Overnutrition, Overweight and Obesity. Sarah E Messiah has authored 368 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 1 of them ongoing. SLR score: 1,311 (community average: 125). How the SLR is computed.
LeadR Profile
Pediatrics
Subspecialties: Nutrition - Public Health - Surgery
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2005 - 2026
Number : 368
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Long-Term Satisfaction with the Choice to Complete Metabolic and Bariatric Surgery: The Hindsight 20/20 Study. PMID 42848282 — bariatric surgery | Obes Surg | 2026 | 0 |
| Online Lifestyle Support for Adolescents Undergoing Metabolic and Bariatric Surgery: Pilot Prospective Cohort Study. PMID 42832767 — pilots, life style, safety, cohort studies, adolescent, bariatric surgery, weight loss, retention, psychology | JMIR Pediatr Parent | 2026 | 0 |
| GLP-1 receptor agonists are associated with lower kidney cancer risk after metabolic bariatric surgery. PMID 42644757 — diabetes mellitus, glucagon-like peptide 1, glucagon-like peptide-1 receptor, insulin, neoplasms, kidney, nephrology, bariatric surgery, kidney neoplasms, obesity, renal dialysis, kidney transplantation, overweight, metformin, diabetes mellitus, type 2 | Nephrol Dial Transplant | 2026 | 0 |
| Updated Waist Circumference Percentiles and Central Obesity Prevalence Among U.S. Children and Adolescents, NHANES 2011-2023. PMID 42593028 — pediatric obesity, aged, adolescent, prevalence, obesity, sex, obesity, abdominal, waist circumference, metabolic syndrome, child | Metab Syndr Relat Disord | 2026 | 0 |
| Comparative risk of hepatocellular carcinoma and mortality among initiators of GLP-1 receptor agonists versus other glucose-lowering therapies: a target trial emulation. PMID 42584814 — liver diseases, glucagon-like peptide 1, mortality, carcinoma, hepatocellular, glucagon-like peptide-1 receptor, insulin, probability, diagnosis, therapeutics, metformin | Hepatol Int | 2026 | 0 |
Clinical Studies 5
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Support and Healing Intervention for Adolescents With a Parent Diagnosed With Cancer (SHINE) NCT07751185 — pilots, health insurance portability and accountability act, communication, neoplasms, psycho-oncology, adaptation, psychological, social work, adolescent, work, survivorship, psychological distress, counseling, psychosocial intervention, education, community support | N/A | Not yet recruiting | 2026 |
LeadR Networks
Main global connection map